FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry. Pharmaceutical composition, made in form of a tablet, contains as active substances - glycine in a dosage of 0.1-0.25 g per tablet and tetramethyltetraazabicyclooctandione in a dosage 0.25-0.5 g per tablet. Pharmaceutically acceptable additives are selected from a group consisting of microcrystalline cellulose, saccharose, polyvinyl pyrrolidone, sodium carboxymethylcellulose, methyl cellulose, starch, colloidal silicon dioxide, talc, stearic acid salt. Pharmaceutical composition is used as an anxiolytic drug.
EFFECT: invention widens range of drugs for treating neurotic disorders and intensified anxiolytic action.
8 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION AND KIT WITH ANXIOLYTIC ACTION | 2017 |
|
RU2703729C2 |
| PHARMACEUTICAL COMPOSITION BASED ON N-BENZYL-N-METHYL-1-PHENYLPYRROLO [1,2-A] PYRAZINE-3-CARBOXAMIDE | 2017 |
|
RU2689396C2 |
| ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
| AGENT POSSESSING ANXIOLYTIC ACTIVITY | 2015 |
|
RU2571286C1 |
| ANXIOLYTIC, SEDATIVE AND ANTI-STRESS MEDICINAL PRODUCT AND METHOD OF ITS OBTAINING | 2023 |
|
RU2814110C1 |
| DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING SEDATIVE AND ANXYOLITIC ACTION | 2008 |
|
RU2361599C1 |
| USE OF AMIDE N-(6-PHENYLHEXANOYL) GLYCYL-L-TRYPTOPHANE (GB-115) AS AN AGENT HAVING ANXIOLYTIC PROPERTIES WITH AN ACTIVATING COMPONENT | 2018 |
|
RU2709013C1 |
| AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION | 2007 |
|
RU2338533C1 |
| PHARMACEUTICAL COMPOSITION SHOWING SOPORIFIC, SEDATIVE AND TRANQUILIZING ACTIVITY, METHOD OF ITS PREPARING | 2001 |
|
RU2183121C1 |
